Results 171 to 180 of about 14,040 (225)

Peroxisome Proliferator-Activated Receptors (PPARs) in Psoriasis: Metabolic Intersections, Molecular Mechanisms, and Potential Treatments. [PDF]

Cureus
Pinnelli VBK, T SB, Ca J, Bhanu P, Murthuza AA, Thipani Madhu M, N S, Sam KT, Hussain MH, As A, Kandi V.   +10 more
europepmc   +1 more source

Elevated FIB-4 index as a risk marker within the KDIGO framework in patients with type 2 diabetes and hypertension. [PDF]

BMJ Open Diabetes Res Care
Fu H, Xing C, Wang H, Wei X, Wirtz S.
europepmc   +1 more source

Effect of Roxadustat and Erythropoietin on Glycated Hemoglobin of Non-Dialysis Type 2 Diabetic Nephropathy Anemia Patients. [PDF]

Biomedicines
Xiang Z, Wei W, Guo S, Meng H, Rong S.
europepmc   +1 more source

Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics. [PDF]

Front Immunol
Zhang Z.
europepmc   +1 more source

Does Pemafibrate Lower Low-Density Lipoprotein-Cholesterol? [PDF]

J Atheroscler Thromb
Fujioka Y.
europepmc   +1 more source

What the European Reference Network Registry for Rare Liver Diseases Tells Us About Primary Biliary Cholangitis in European Practice. [PDF]

United European Gastroenterol J
Lantinga MA.
europepmc   +1 more source

Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue. [PDF]

Sci Rep
Moldovan I, Fechete R, Bîrla A, Orban E, Sipos RS.   +4 more
europepmc   +1 more source

Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor. [PDF]

Biomedicines
Jamal F, Elshaer A, Alatout MH, Odeh NB, Youssef A, Abo Abdullah H, Elmasry S, Shahin T, Abdul Nabi H, Worden AR, Malik TA, Lizaola-Mayo BC.   +11 more
europepmc   +1 more source

Dyslipidaemia and cardiovascular risk - Key considerations in South Asians. [PDF]

Clin Med (Lond)
Chauhan A, Sahota S, Jegatheeswaran L, Johal HK, Minhas R, Patel P, Gupta P, Patel V, Banerjee A, Patel K, Singh A.   +10 more
europepmc   +1 more source